RXP470.1 | RXP470 | CAS#891198-31-5 | MMP-12 inhibitor

MedKoo Cat#: 532604 | Name: RXP470

Description:

WARNING: This product is for research use only, not for human or veterinary use.

RXP470, also known as RXP470.1, is a potent and selective MMP-12 inhibitor (Ki 0.24 nM) and 3D structure 4GQL. It was reported to reduce atherosclerotic plaque development in apolipoprotein E-knockout mice.

Chemical Structure

RXP470

CAS#891198-31-5

Theoretical Analysis

MedKoo Cat#: 532604

Name: RXP470

CAS#: 891198-31-5

Chemical Formula: C35H35BrClN4O10P

Exact Mass: 816.0963

Molecular Weight: 818.01

Elemental Analysis: C, 51.39; H, 4.31; Br, 9.77; Cl, 4.33; N, 6.85; O, 19.56; P, 3.79

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

RXP470.1; RXP 470.1; RXP-470.1; RXP470; RXP 470; RXP-470.

IUPAC/Chemical Name

(4S)-5-amino-4-((2S)-2-((2S)-3-((4-bromophenyl)(hydroxy)phosphoryl)-2-((3-(3'-chloro-[1,1'-biphenyl]-4-yl)isoxazol-5-yl)methyl)propanamido)-4-carboxybutanamido)-5-oxopentanoic acid

InChi Key

PTUCPHGSAFOJAU-MGONOCMRSA-N

InChi Code

InChI=1S/C35H35BrClN4O10P/c36-24-8-10-27(11-9-24)52(49,50)19-23(34(47)40-29(13-15-32(44)45)35(48)39-28(33(38)46)12-14-31(42)43)17-26-18-30(41-51-26)21-6-4-20(5-7-21)22-2-1-3-25(37)16-22/h1-11,16,18,23,28-29H,12-15,17,19H2,(H2,38,46)(H,39,48)(H,40,47)(H,42,43)(H,44,45)(H,49,50)/t23-,28+,29+/m1/s1

SMILES Code

O=C(O)CC[C@H](NC([C@@H](NC([C@H](CC1=CC(C2=CC=C(C3=CC=CC(Cl)=C3)C=C2)=NO1)CP(O)(C4=CC=C(Br)C=C4)=O)=O)CCC(O)=O)=O)C(N)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 818.01 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1. Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V. (2013) Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies. J. Med. Chem., 56 (3): 1149-59. [PMID:23343195] 2. Johnson JL, Devel L, Czarny B, George SJ, Jackson CL, Rogakos V, Beau F, Yiotakis A, Newby AC, Dive V. (2011) A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Arterioscler. Thromb. Vasc. Biol., 31 (3): 528-35. [PMID:21212406]